First COVID-19 Vaccine Dose Elicits Weak Antibody Response in Most KTRs

Loading

“Most adult kidney transplant recipients (KTRs) exhibit a weak antibody response to the first injection of the Moderna mRNA COVID-19 vaccine, according to the findings of a prospective study published in Kidney International.1

“We already know that kidney transplant recipients tend to respond less well to vaccines because of the immunosuppression, but data concerning the anti-SARS-CoV-2 antibody response after COVID-19 vaccine in this population were lacking,” said first author Ilies Benotmane, MD, of Strasbourg University Hospital and the Fédération de Médecine Translationnelle (FMTS) in Strasbourg, France.

COVID-19 vaccine distribution programs worldwide have given priority to immunocompromised patients, including KTRs. Vaccination was recommended, however, for this patient population even though KTRs were not included in the vaccine clinical trials. Dr Benotmane and colleagues conducted a preliminary study investigating the efficacy and safety of the Moderna mRNA-1273 vaccine in KTRs by looking at the anti SARS CoV-2 antibody response after the first injection.”

Read more, here.

Loading

Removing Race from Estimates of Kidney Function: What Happens Next?

Loading

“The American Society of Nephrology (ASN) and the National Kidney Foundation (NKF) announce the concurrent publication of “Special Article: Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report from the NKF-ASN Task Force” in the Journal of the American Society of Nephrology(JASN) and the American Journal of Kidney Diseases (AJKD).

The publication in JASN and AJKD provides an essential review of the many challenges relative to identifying and implementing alternative methods to diagnosing kidney diseases. Last month, ASN and NKF asserted that race modifiers should not be included in equations used to estimate kidney function. ASN and NKF also stated that current race-based equations should be replaced by a substitute that is accurate, representative, unbiased, and provides a standardized approach to diagnosing kidney diseases.”

Read the full article, here.

Loading

Preguntas Frecuentes Acerca del COVID-19

Loading

“La División de Trasplantes (DoT, siglas en inglés) de la Administración de Recursos y Servicios de Salud (HRSA, siglas en inglés) está controlando el impacto de la emergencia de salud pública por coronavirus (COVID-19) sobre la procuración y el trasplante de órganos.

¿Debería inscribirme como donante de órganos durante el brote de COVID-19?

Si no es donante de órganos registrado, le sugerimos que se inscriba en línea a través de su registro estatal de donantes. Inscribirse significa que, algún día, podría salvar vidas.”

Mas informacion aqui.

Loading

Japanese Doctors Perform World’s First Living Donor Lung Transplant on COVID-19 Patient

Loading

“A COVID-19 patient in Japan has received the world’s first lung transplant from living donors.

Receiving transplant lung tissue from her son and husband, the patient underwent an 11-hour operation at Kyoto University Hospital to receive her transplant last Wednesday.

The woman who underwent the operation contracted COVID-19 late last year. According to Kyoto University Hospital, she spent months on a life support machine acting as an artificial lung, because hers had become no longer functional. It’s expected that she’ll recover from last week’s operation within months.”

Read the full story, here.

Loading

PTC: Cancer Risks for Kidney Recipients

Loading

WHY AM I AT GREATER RISK OF DEVELOPING CANCER AFTER KIDNEY TRANSPLANT?

“All organ transplant recipients are at heightened risk of developing cancer after transplant. This is because although life-sustaining, long-term use of immunosuppressant drugs lowers the body’s ability to fend off certain cancers. When you are taking immunosuppressant drugs, your immune response is lowered, and this is what helps to prevent your body from rejecting your new kidney. It also means that your body is less able to recognize and destroy cancer cells or infections that can cause cancer.”

Read more on TRIO’s new Post-transplant Cancer Project (PTC) website, here.

Loading

Recipe: Egg Roll in a Bowl

Loading

Ingredients:

Meat

  • 1 lb. ground turkey or beef

Produce

  • 5 cups shredded cabbage
  • 1 cup shredded carrots
  • 3 cloves minced garlic
  • 1/2 tsp grated fresh ginger
  • 1 chopped green onion
  • 1 1/2 cup diced sweet onion

Canned Goods

  • 1/4 cup chicken broth

Baking & Spices

  • 1/4 tsp pepper
  • 1/2 tsp salt
  • 1 sesame seeds, toasted

Oils & Vinegars

  • 2 tsp apple cider vinegar
  • 2 tbsp olive oil
  • 1 tsp sesame oil, toasted
  • Nuts & seeds
  • 2 tbsp coconut aminos

Directions

  1. Sauté olive oil and ground turkey in a large sauté pan over medium heat.
  2. Cook for 5-6 minutes, or until turkey is almost cooked through.
  3. Push turkey to the side of the pan and add onion and the other tablespoon of oil.
  4. Sauté for 3-4 minutes.
  5. Add shredded carrots, garlic, and ginger and sauté for 2 minutes. Stir the vegetables and turkey together.
  6. Pour chicken broth in the pan and scrape the bottom of it to deglaze it.
  7. Add cabbage, coconut aminos or soy sauce, vinegar, salt, and pepper. Stir well and cover with a lid.
  8. Reduce heat to medium-low and cook for 12-15 minutes, or until cabbage is to your desired tenderness.
  9. Just before serving add toasted sesame oil and stir to combine.

Loading

The ‘Heart’ of the Matter is That an Organ Donation Saved Sam Dey’s Life

Loading

In 2009, Sam Dey was working for General Motors and in India on business.

It was during that business trip that Sam started falling.

“I was collapsing and falling in these incredibly crowded streets of India,” says Sam. “I was falling everywhere, and people were always pouring water on my face to revive me.”

Doctors in India told Sam—who had congestive heart failure and type 2 diabetes—that his badly damaged heart would prevent him from returning to the United States.

Sam ended up being stranded in India from 2009 until 2014.

Read Sam’s full story, here.

Loading

How Common is Cancer in Organ Transplant Recipients?

Loading

As an organ transplant recipient, you already “know” several things:

  • You know what the anxiety and stress of end-stage organ disease feels like
  • You know that your life has been improved after receiving your transplant
  • You know that by taking care of your transplant, you can reduce the risk of rejection of the organ

Did you also know that the important immunosuppressants (anti-rejection medications) you take to prevent your body from rejecting your transplanted kidney, heart, lung, or liver may increase your risk of developing certain types of
cancer?1

While the risk of dying from cancer is low, you need to be proactive and get screened for various types of cancer—most notably skin cancer.

Read the full article, here.

Loading

Prescription Discount and Assistance Resources

Loading

“Use the card to receive discounts on prescriptions while helping fight kidney disease at the same time. All medications are eligible for savings, including pet meds! Every time you save using the card, the National Kidney Foundation will receive a donation from Watertree Health, at no cost to you.”

Check out more information about the program, here.

Loading